ES8106152A1 - Un procedimiento para la preparacion de derivados de 4-hidroxi-tetrahidropiran 2- ona. - Google Patents

Un procedimiento para la preparacion de derivados de 4-hidroxi-tetrahidropiran 2- ona.

Info

Publication number
ES8106152A1
ES8106152A1 ES494301A ES494301A ES8106152A1 ES 8106152 A1 ES8106152 A1 ES 8106152A1 ES 494301 A ES494301 A ES 494301A ES 494301 A ES494301 A ES 494301A ES 8106152 A1 ES8106152 A1 ES 8106152A1
Authority
ES
Spain
Prior art keywords
dihydroxy acids
phenylethenyl
ones
preparing
stereoisomeric forms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES494301A
Other languages
English (en)
Other versions
ES494301A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8106152A1 publication Critical patent/ES8106152A1/es
Publication of ES494301A0 publication Critical patent/ES494301A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C67/347—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to unsaturated carbon-to-carbon bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE DERIVADOS DE 4-HIDROXITETRAHIDROPIRAN 2-ONA. SE REFIERE A LA PREPARACION DE COMPUESTOS DE ESTRUCTURA (I), DONDE A ES HIDROGENO O METILO, E ES UN ENLACE DEL TIPO (II) O (III), R1 ESTA SITUADO EN POSICION ORTO RESPECTO AL RADICAL E Y ES HALOFENILOXI, HALOFENIALCOXI O HALOFENILO, ESPECIALMENTE DONDE HALO ES FLUOR O CLORO; R2 Y R3 SON HALO, ESPECIALMENTE CLORO, EN LAS POSICIONES 4 Y 6. TAMBIEN SE REFIERE A LOS HIDROXIACIDOS RESULTANTES DE LA APERTURA HIDROLITICA DEL ANILLO DE LACTONA, LAS SALES FARMACEUTICAMENTE ACEPTABLES DE LOS HIDROXIACIDOS Y LOS ESTERES ALQUILICOS INFERIORES, FENILICOS Y DIMETILAMINO. PARA SU PREPARACION SE HACE REACCIONAR EL DIANION DE UN ESTER ACETOACETICO CON UN ALDEHIDO DE ESTRUCTURA (IV). SE REDUCE EL GRUPO 3-CETO A GRUPO HIDROXILO. SE SAPONIFICA EL ESTER Y SE LACTONIZA EL CARBOXILO CON EL 6-HIDROXILO. SE UTILIZAN COMO INHIBIDORES DE LA SINTESIS DEL COLESTEROL. *FORMULA*
ES494301A 1979-08-17 1980-08-14 Un procedimiento para la preparacion de derivados de 4-hidroxi-tetrahidropiran 2- ona. Granted ES494301A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6757479A 1979-08-17 1979-08-17

Publications (2)

Publication Number Publication Date
ES8106152A1 true ES8106152A1 (es) 1981-07-16
ES494301A0 ES494301A0 (es) 1981-07-16

Family

ID=22076933

Family Applications (1)

Application Number Title Priority Date Filing Date
ES494301A Granted ES494301A0 (es) 1979-08-17 1980-08-14 Un procedimiento para la preparacion de derivados de 4-hidroxi-tetrahidropiran 2- ona.

Country Status (24)

Country Link
EP (1) EP0024348B1 (es)
JP (1) JPS5645470A (es)
KR (1) KR840002170B1 (es)
AT (1) ATE16487T1 (es)
AU (1) AU6108580A (es)
CA (1) CA1137989A (es)
CS (1) CS219921B2 (es)
DD (1) DD152558A5 (es)
DE (1) DE3071230D1 (es)
DK (1) DK353680A (es)
ES (1) ES494301A0 (es)
FI (1) FI802582A (es)
GR (1) GR69938B (es)
HU (1) HU182190B (es)
IE (1) IE50789B1 (es)
IL (1) IL60751A (es)
MA (1) MA18929A1 (es)
NO (1) NO155491C (es)
NZ (1) NZ194557A (es)
PL (2) PL132249B1 (es)
PT (1) PT71672B (es)
YU (1) YU207180A (es)
ZA (1) ZA805016B (es)
ZW (1) ZW19080A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440927A (en) * 1981-06-19 1984-04-03 Merck & Co., Inc. Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
US4588820A (en) * 1984-06-11 1986-05-13 Merck & Co., Inc. Process for epimerization at C6 of 3,4,5,6-tetrahydro-2H-pyran-2-one
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
DE3615620A1 (de) * 1986-05-09 1987-11-12 Hoechst Ag 4(r)-substituierte 6(s)-phenoxymethyl-, 6(s)-(beta)-phenylaethyl-und 6(s)-(beta)-styryl-tetrahydropyran-2-one, ein hochstereoselektives verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US4898949A (en) * 1987-02-25 1990-02-06 Bristol-Myers Company Intermediates for the preparation of antihypercholesterolemic tetrazole compounds
US5169976A (en) * 1987-11-25 1992-12-08 Pfizer Inc. N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives
JP3171931B2 (ja) * 1992-06-02 2001-06-04 高砂香料工業株式会社 （Ｒ）−（−）−４−シアノ−３−ヒドロキシ酪酸ｔ−ブチルエステル及びその製造方法
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
RU2563831C1 (ru) * 2014-10-13 2015-09-20 Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук Применение протатран 4-хлор-2-метилфеноксиацетата (хлоркрезацина) для угнетения активности холестеролэстеразы
WO2016161085A1 (en) 2015-04-01 2016-10-06 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent

Also Published As

Publication number Publication date
JPH0257550B2 (es) 1990-12-05
EP0024348A1 (en) 1981-03-04
CS219921B2 (en) 1983-03-25
NO155491C (no) 1987-04-08
ZW19080A1 (en) 1982-03-17
EP0024348B1 (en) 1985-11-13
PL127979B1 (en) 1983-12-31
DD152558A5 (de) 1981-12-02
IE801732L (en) 1981-02-17
IL60751A (en) 1985-04-30
MA18929A1 (fr) 1981-04-01
NZ194557A (en) 1984-09-28
GR69938B (es) 1982-07-21
JPS5645470A (en) 1981-04-25
IL60751A0 (en) 1980-10-26
NO802431L (no) 1981-02-18
ATE16487T1 (de) 1985-11-15
PT71672A (en) 1980-09-01
YU207180A (en) 1983-02-28
FI802582A (fi) 1981-02-18
PT71672B (en) 1982-01-22
KR840002170B1 (ko) 1984-11-26
ES494301A0 (es) 1981-07-16
IE50789B1 (en) 1986-07-23
ZA805016B (en) 1982-03-31
CA1137989A (en) 1982-12-21
NO155491B (no) 1986-12-29
KR830003465A (ko) 1983-06-20
PL226285A1 (es) 1981-03-27
HU182190B (en) 1983-12-28
DK353680A (da) 1981-02-19
AU6108580A (en) 1981-02-19
DE3071230D1 (en) 1985-12-19
PL132249B1 (en) 1985-02-28

Similar Documents

Publication Publication Date Title
ES8106152A1 (es) Un procedimiento para la preparacion de derivados de 4-hidroxi-tetrahidropiran 2- ona.
HUT52059A (en) Process for producing pharmaceutical compositions and new quinoline derivatives as a group of active components
ES8600765A1 (es) Procedimiento de preparar derivados de penicilina
DE3071764D1 (en) 6-(1-hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acids, a process for preparing the same, an antibiotic pharmaceutical composition comprising the same, intermediates useful in a synthesis of that kind and processes for preparing intermediates suitable for the synthesis of that kind
HUT54683A (en) Process for producing piridazine derivatives
HUT46895A (en) Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect
LV10235A (lv) Jauni esteri to iegusanas panemiens farmaceitiska kompozicija arstesanas metode
MY107567A (en) A method for the preparation in a non-racemic form of furo (3,4-c) pyridine derivatives.
AU576530B2 (en) 1,3-dioxan-4-yl alkenoic acids
PT74656B (en) Process for preparing morpholines
AU590455B2 (en) Process for preparing penems